Health & Fitness

Pneumonia Market Overview: The 7 major pneumonia markets are expected to exhibit a CAGR of 5.6% during 2023-2033. The report offers a comprehensive analysis of the pneumonia market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and Japan. It covers aspects such as treatment methods, drugs available in the market, drugs in development, the proportion of various therapies, and the market’s performance in the seven major regions. Additionally, the report evaluates the performance of leading companies and their pharmaceutical products. Current and projected patient numbers across these key markets are also detailed in the report. This study is essential for manufacturers, investors, business planners, researchers, consultants, and anyone interested or involved in the pneumonia market. Request for a Sample of this Report: https://www.imarcgroup.com/pneumonia-market/requestsample The pneumonia market is influenced by many factors ... Continue reading →

Market Overview: The 7 major medulloblastoma markets are expected to exhibit a CAGR of 6.3% during 2023-2033. The report offers a comprehensive analysis of the medulloblastoma market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and Japan. It covers aspects such as treatment methods, drugs available in the market, drugs in development, the proportion of various therapies, and the market’s performance in the seven major regions. Additionally, the report evaluates the performance of leading companies and their pharmaceutical products. Current and projected patient numbers across these key markets are also detailed in the report. This study is essential for manufacturers, investors, business planners, researchers, consultants, and anyone interested or involved in the medulloblastoma market. Request for a Sample of this Report: https://www.imarcgroup.com/medulloblastoma-market/requestsample Medulloblastoma refers to a type of cancer ... Continue reading →

How big is the chronic pain market? The 7 major chronic pain markets reached a value of US$ 20.6 Billion in 2022. Looking forward, IMARC Group expects the 7MM to reach US$ 28.5 Billion by 2033, exhibiting a growth rate (CAGR) of 3.01% during 2023-2033. The report offers a comprehensive analysis of the chronic pain market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and Japan. It covers aspects such as treatment methods, drugs available in the market, drugs in development, the proportion of various therapies, and the market’s performance in the seven major regions. Additionally, the report evaluates the performance of leading companies and their pharmaceutical products. Current and projected patient numbers across these key markets are also detailed in the report. This study is essential for manufacturers, investors, business planners, researchers, consultants, and anyone interested or involved in the chronic pain market. Request a ... Continue reading →

Market Overview: The 7 major metabolic acidosis markets are expected to exhibit a CAGR of 6% during 2023-2033. The report offers a comprehensive analysis of the metabolic acidosis market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and Japan. It covers aspects such as treatment methods, drugs available in the market, drugs in development, the proportion of various therapies, and the market’s performance in the seven major regions. Additionally, the report evaluates the performance of leading companies and their pharmaceutical products. Current and projected patient numbers across these key markets are also detailed in the report. This study is essential for manufacturers, investors, business planners, researchers, consultants, and anyone interested or involved in the metabolic acidosis market. Request for a Sample of this Report: https://www.imarcgroup.com/metabolic-acidosis-market/requestsample The metabolic acidosis market has ... Continue reading →

Market Overview: The 7 major musculoskeletal pain markets reached a value of US$ 3,751.9 Million in 2022. Looking forward, IMARC Group expects the 7MM to reach US$ 5,325.2 Million by 2033, exhibiting a growth rate (CAGR) of 2.94% during 2023-2033. The report offers a comprehensive analysis of the musculoskeletal pain market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and Japan. It covers aspects such as treatment methods, drugs available in the market, drugs in development, the proportion of various therapies, and the market’s performance in the seven major regions. Additionally, the report evaluates the performance of leading companies and their pharmaceutical products. Current and projected patient numbers across these key markets are also detailed in the report. This study is essential for manufacturers, investors, business planners, researchers, consultants, and anyone interested or involved in the musculoskeletal pain market. ... Continue reading →

Today, human tissue banking offers a wide range of opportunities and is essential to contemporary medical research. The specialized, licensed facilities known as tissue banks gather, process, store, and distribute human tissues for clinical transplantation, medical research, and educational purposes. Tissue banking is an idea that is as old as skin grafting itself. Typically, human tissues specimens for banking are obtained from the human body while the patient is still alive during a clinical procedure, a biopsy, or surgery. The tissue samples may occasionally be taken from individuals who have died. After being examined, the collected human tissues are prepared for usage in sterile cryogenic units by processing and preserving them in tissue banks. Additionally, rigorous quality control is used to preserve the integrity of the samples and stop tissue damage due to natural processes like necrosis and apoptosis.  Use of Human Tissue Samples This age has seen a rise in the ... Continue reading →

Today, human tissue banking offers a wide range of opportunities and is essential to contemporary medical research. The specialized, licensed facilities known as tissue banks gather, process, store, and distribute human tissues for clinical transplantation, medical research, and educational purposes. Tissue banking is an idea that is as old as skin grafting itself. Typically, human tissues specimens for banking are obtained from the human body while the patient is still alive during a clinical procedure, a biopsy, or surgery. The tissue samples may occasionally be taken from individuals who have died. After being examined, the collected human tissues are prepared for usage in sterile cryogenic units by processing and preserving them in tissue banks. Additionally, rigorous quality control is used to preserve the integrity of the samples and stop tissue damage due to natural processes like necrosis and apoptosis.  Use of Human Tissue Samples This age has seen a rise in the ... Continue reading →

Peripheral Blood Mononuclear Cells (PBMCs) are a group of blood cells such as lymphocytes (T-cells, B-cells and NK cells), monocytes, and dendritic cells that play an essential role in modulating immunity in humans. It is also known as agranulocytes. PBMCs defend the body against cancer and other human pathogenic diseases and infections. How are Peripheral Blood Mononuclear Cells produced? Peripheral Blood Mononuclear Cells are produced from haematopoietic stem cells in the bone marrow by the process of haemopoiesis. During hematopoiesis, the cells differentiate to form distinct lineages called myeloid and lymphoid. PBMCs are released into the peripheral bloodstream to promote immunity; they normally contain rounded single-nucleated lymphoid cells and specific myeloid cells. In the fight against bacteria, viruses, fungi, and other external invaders of the human body, these cells serve as the immune system's main engine. PBMCs serve as our body's first line of defence. ... Continue reading →

Parkinson's disease is a condition that can severely impact a person's life. It causes a range of symptoms, including shaking, stiffness, difficulty balancing, and coordination issues. This disease is caused by the death of specific neurons in the brain, which leads to the formation of Lewy bodies and motor impairment. The condition is also known as parkinsonism. Despite many years of research, we still need to understand the cause of this disease fully. Unfortunately, the prevalence of Parkinson's disease is on the rise, making it more important than ever to find better diagnostic tests and effective treatments.   What are Parkinson's disease symptoms?   Parkinson's disease is a progressive disorder with symptoms worsening over time. Early signs of Parkinson's disease include tremors while at rest, rigid limbs and trunks, slow movement, and balance problems. As the disease advances, individuals may experience difficulty with swallowing, walking, ... Continue reading →

Alzheimer's is a neurological disorder characterized by brain atrophy that can lead to severe memory loss. It is the leading cause of dementia worldwide, as patients gradually lose their cognitive abilities and other mental skills, eventually becoming unable to function independently. While family history and advancing age are among the most significant risk factors for Alzheimer's disease, its specific cause remains uncertain. Nevertheless, it is a major illness associated with ageing and impacts millions of individuals globally. Alzheimer's disease causes Research efforts are underway globally to uncover the precise aetiology of Alzheimer's disease. Nonetheless, the most prominent determinant influencing disease progression is age, as individuals over 65 are at a greater risk of developing the condition than younger adults. Additionally, having a family history of the disease is strongly associated with its incidence. Other extrinsic factors, such as diet, lifestyle, ... Continue reading →